Continue to Cover for Atypicals in Hospitalized Pneumonia Patients

You'll hear debate about whether it's okay to use a beta-lactam ALONE in hospitalized patients with community-acquired pneumonia (CAP).

Guidelines recommend using a beta-lactam (ceftriaxone, etc) plus a macrolide (azithromycin, etc)...OR a respiratory quinolone (levofloxacin, etc)...in non-ICU CAP patients. The idea is to help cover atypicals such as Mycoplasma or Legionella.

Now new evidence suggests that beta-lactam monotherapy is associated with similar 90-day mortality as a beta-lactam/macrolide combo or respiratory quinolone monotherapy in hospitalized patients.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote